Meeting to be held on August 26-28 hosted by Piper Sandler.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALLO:
- Allogene Therapeutics Faces Financial Uncertainty Amid New U.S. Tariffs and Regulatory Challenges
- Promising Pipeline and Strategic Advancements Drive Buy Rating for Allogene Therapeutics
- Allogene Therapeutics Advances in CAR T Cell Therapy
- Allogene Therapeutics reports Q2 EPS (23c), consensus (27c)
- Allogene Therapeutics options imply 16.7% move in share price post-earnings